Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
Utility of nematode small molecules
US9868754B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9868754-B2 |
| Application number | US-201214237795-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2012 |
| Priority date | Aug 8, 2011 |
| Publication date | Jan 16, 2018 |
| Grant date | Jan 16, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of alleviating or treating an inflammatory disorder in a human subject, comprising: administering to the subject a composition comprising isolated ascr#7 or a salt thereof; and wherein the inflammatory disorder is asthma, inflammatory bowel disease, or type one diabetes. 2. The method of claim 1 , wherein the method reduces mucus production in the subject. 3. The method of claim 1 , wherein the naturally occurring ascaroside is produced from a Nippostrongylus brasiliensis. 4. The method of claim 1 , wherein the inflammatory disorder is asthma. 5. The method of claim 1 , wherein the inflammatory disorder is inflammatory bowel disease. 6. The method of claim 1 , wherein the inflammatory disorder is type one diabetes.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9868754B2 cover?
- The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture …
- Who is the assignee on this patent?
- Choe Andrea, Sternberg Paul W, Schroeder Frank C, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07H15/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).